The chewable, mint flavoured tablets give "fast and effective relief" from "three of the most common digestive health ailments", the manufacturer...
This announcement comes after "supply disruption and volatility" of the "low molecular weight heparin market" has left pharmacies "managing scarce...
The campaign hits the airwaves today (October 23), with another series of advertisements to follow from November 20. Perrigo is “excited” about the...
Inhixa has “clinically proven efficacy”, the manufacturer claimed, and can also be used for venous thromboembolism prophylaxis and the treatment of...
Download the C+D app today for free on your iOS or Android phone or tablet. Access the latest and most popular news.
SIGN UP FOR OUR NEWSLETTERS
- C+D Daily Bulletin
- • C+D CPD Bulletin
- • C+D Saturday Review
- • C+D Careers Bulletin
- • C+D Briefing Newsletter